Literature DB >> 26600986

[Microsurgical anatomy and approaches of mesial temporal cavernomas].

Alvaro Campero1.   

Abstract

OBJECTIVE: To describe the microsurgical anatomy and approaches to the mesial temporal region (MTR), in relation with cavernomas.
METHODS: Five adult cadaveric heads, fixed in formol and injected with colored silicon were studied. Since January 2007 and June 2014, the author operated 7 patients with cavernomas located in the MTR. ANATOMY: The MTR was divided in 3 portions: Anterior, middle and posterior. PATIENTS: The author operated 7 patients with MTR cavernomas. Four cavernomas were located in the anterior portion, 2 were located in the middle portion, and 1 cavernoma was located in the posterior portion. The transsylvian-transinsular approach was used for the anterior portion of the MTR; the transtemporal approach (anterior temporal lobectomy) was used for the middle portion of the MTR; and the supracerebellar-transtentorial approach was used for the posterior portion of the MTR.
CONCLUSION: The idea of divide the MTR in 3 portions help to select the correct approach.

Entities:  

Year:  2015        PMID: 26600986      PMCID: PMC4623614          DOI: 10.4103/2152-7806.167204

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


  11 in total

1.  Microsurgical approaches to the medial temporal region: an anatomical study.

Authors:  Alvaro Campero; Gustavo Tróccoli; Carolina Martins; Juan C Fernandez-Miranda; Alexandre Yasuda; Albert L Rhoton
Journal:  Neurosurgery       Date:  2006-10       Impact factor: 4.654

Review 2.  Microsurgical treatment of temporal lobe cavernomas.

Authors:  Juri Kivelev; Mika Niemelä; Göran Blomstedt; Reina Roivainen; Martin Lehecka; Juha Hernesniemi
Journal:  Acta Neurochir (Wien)       Date:  2010-09-26       Impact factor: 2.216

3.  The paramedian supracerebellar-transtentorial approach to the entire length of the mediobasal temporal region: an anatomical and clinical study. Laboratory investigation.

Authors:  Uğur Türe; Mehmet Volkan Harput; Ahmet Hilmi Kaya; Praveen Baimedi; Zeynep Firat; Hatice Türe; Canan Aykut Bingöl
Journal:  J Neurosurg       Date:  2012-01-20       Impact factor: 5.115

4.  Supracerebellar transtentorial approach-resection of the tentorium instead of an opening-to provide broad exposure of the mediobasal temporal lobe: anatomical aspects and surgical applications: clinical article.

Authors:  Jean G de Oliveira; Richard Gonzalo Párraga; Feres Chaddad-Neto; Guilherme Carvalhal Ribas; Evandro P L de Oliveira
Journal:  J Neurosurg       Date:  2012-01-13       Impact factor: 5.115

Review 5.  Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series.

Authors:  N F Moran; D R Fish; N Kitchen; S Shorvon; B E Kendall; J M Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

Review 6.  Anatomic principles of cerebrovascular surgery for arteriovenous malformations.

Authors:  E de Oliveira; H Tedeschi; M G Siqueira; M Ono; A L Rhoton; D Peace
Journal:  Clin Neurosurg       Date:  1994

7.  Access to the posterior medial temporal lobe structures in the surgical treatment of temporal lobe epilepsy.

Authors:  D D Spencer; S S Spencer; R H Mattson; P D Williamson; R A Novelly
Journal:  Neurosurgery       Date:  1984-11       Impact factor: 4.654

8.  Selective amygdalo-hippocampectomy. Operative anatomy and surgical technique.

Authors:  M G Yaşargil; P J Teddy; P Roth
Journal:  Adv Tech Stand Neurosurg       Date:  1985

9.  Cerebral cavernous haemangiomas or cavernomas. Incidence, pathology, localization, diagnosis, clinical features and treatment. Review of the literature and report of an unusual case.

Authors:  K Voigt; M G Yaşargil
Journal:  Neurochirurgia (Stuttg)       Date:  1976-03

10.  White matter fiber dissection of the optic radiations of the temporal lobe and implications for surgical approaches to the temporal horn.

Authors:  Eric H Sincoff; Yunxi Tan; Saleem I Abdulrauf
Journal:  J Neurosurg       Date:  2004-11       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.